Upstream Bio Inc (UPB) Wheel Strategy

Running a UPB wheel strategy lets you generate consistent premium income on Upstream Bio Inc while setting your own entry and exit prices on the underlying. Upstream Bio Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own UPB, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best UPB wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on UPB, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable UPB wheel from a losing one.

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the UPB wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your UPB wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.